Literature DB >> 24026630

Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™).

Andrew Lloyd1, Cicely Kerr, Katie Breheny, John Brazier, Aurora Ortiz, Emma Borg.   

Abstract

PURPOSE: Condition-specific preference-based measures can offer utility data where they would not otherwise be available or where generic measures may lack sensitivity, although they lack comparability across conditions. This study aimed to develop an algorithm for estimating utilities from the short bowel syndrome health-related quality of life scale (SBS-QoL™).
METHODS: SBS-QoL™ items were selected based on factor and item performance analysis of a European SBS-QoL™ dataset and consultation with 3 SBS clinical experts. Six-dimension health states were developed using 8 SBS-QoL™ items (2 dimensions combined 2 SBS-QoL™ items). SBS health states were valued by a UK general population sample (N = 250) using the lead-time time trade-off method. Preference weights or 'utility decrements' for each severity level of each dimension were estimated by regression models and used to develop the scoring algorithm.
RESULTS: Mean utilities for the SBS health states ranged from -0.46 (worst health state, very much affected on all dimensions) to 0.92 (best health state, not at all affected on all dimensions). The random effects model with maximum likelihood estimation regression had the best predictive ability and lowest root mean squared error and mean absolute error, and was used to develop the scoring algorithm.
CONCLUSIONS: The preference-weighted scoring algorithm for the SBS-QoL™ developed is able to estimate a wide range of utility values from patient-level SBS-QoL™ data. This allows estimation of SBS HRQL impact for the purpose of economic evaluation of SBS treatment benefits.

Entities:  

Mesh:

Year:  2013        PMID: 24026630     DOI: 10.1007/s11136-013-0516-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  33 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

Review 2.  The medical and surgical management of short bowel syndrome.

Authors:  Alan L Buchman
Journal:  MedGenMed       Date:  2004-05-13

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

Authors:  Donna Rowen; John Brazier; Tracey Young; Sabine Gaugris; Benjamin M Craig; Madeleine T King; Galina Velikova
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

Review 5.  A review of the quality of life of adult patients treated with long-term parenteral nutrition.

Authors:  Janet P Baxter; Peter M Fayers; Alastair W McKinlay
Journal:  Clin Nutr       Date:  2006-07-03       Impact factor: 7.324

6.  Short bowel syndrome and intestinal failure: consensus definitions and overview.

Authors:  Stephen J D O'Keefe; Alan L Buchman; Thomas M Fishbein; Khursheed N Jeejeebhoy; Palle Bekker Jeppesen; Jonathan Shaffer
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

7.  A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.

Authors:  Nancy J Devlin; Aki Tsuchiya; Ken Buckingham; Carl Tilling
Journal:  Health Econ       Date:  2011-03       Impact factor: 3.046

8.  An exploration of quality of life and the experience of living with home parenteral nutrition.

Authors:  Marion F Winkler; Elizabeth Hagan; Terri Wetle; Carol Smith; Julie O'Sullivan Maillet; Riva Touger-Decker
Journal:  JPEN J Parenter Enteral Nutr       Date:  2010 Jul-Aug       Impact factor: 4.016

9.  Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms.

Authors:  Evangelos Kalaitzakis; Eva Carlsson; Axel Josefsson; Ingvar Bosaeus
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

Review 10.  How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.

Authors:  Diana Papaioannou; John Brazier; Glenys Parry
Journal:  Value Health       Date:  2011-07-28       Impact factor: 5.725

View more
  4 in total

1.  Discrepancies between the Dermatology Life Quality Index and utility scores.

Authors:  Fanni Rencz; Petra Baji; László Gulácsi; Sarolta Kárpáti; Márta Péntek; Adrienn Katalin Poór; Valentin Brodszky
Journal:  Qual Life Res       Date:  2015-12-18       Impact factor: 4.147

Review 2.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

Review 3.  The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.

Authors:  Donna Rowen; John Brazier; Roberta Ara; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 4.  Dimensions Used in Instruments for QALY Calculation: A Systematic Review.

Authors:  Moustapha Touré; Christian R C Kouakou; Thomas G Poder
Journal:  Int J Environ Res Public Health       Date:  2021-04-21       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.